Practicality, validity and responsiveness of using the proxy version of the CHU-9D with children aged 2 to 5 years: use of the proxy CHU-9D for children aged 2 to 5
Practicality, validity and responsiveness of using the proxy version of the CHU-9D with children aged 2 to 5 years: use of the proxy CHU-9D for children aged 2 to 5
Objectives: This study aimed to assess the practicality, validity, and responsiveness of the proxy Child Health Utility–9 Dimensions (CHU9D) in children aged 2 to 5 years. Methods: We used data from the Barrier Enhancement for Eczema Prevention trial, a UK randomized controlled trial testing whether daily emollients in infancy could prevent eczema in high-risk infants. The main parent/carer completed the proxy CHU9D using developers’ additional guidance for completion in those younger than 5 years and the Patient-Oriented Eczema Measure (POEM) at ages 2, 3, 4, and 5 years. Practicality was assessed by completion rates. Construct validity assessed whether CHU9D could discriminate between those with/without eczema and between eczema severity levels on POEM. Responsiveness was determined by ability to discriminate between 3 groups: (1) those whose POEM score deteriorated ≥3 points, (2) those whose change was not clinically important (−2.9 to 2.9 points), and (3) those whose POEM score improved ≥3 points. Analysis was conducted in Stata 17. Results: Of 1394 children participating in the Barrier Enhancement for Eczema Prevention trial, study questionnaires were completed by 1212 (87%), 981 (70%), 990 (71%), and 976 (70%) at 2, 3, 4, and 5 years. Of these the CHU9D was completed by 1066 (88.0%), 685 (69.8%), 925 (93.4%), and 923 (94.6%), respectively. Mean utility at all time points was approximately 0.934 (range 0.443-1). For construct validity, very small differences in the CHU9D between known groups were observed (P < .01). A total of 801 participants had responsiveness data: 13% deteriorated, 72% had nonclinically important change, and 15% improved. Mean utility change (standardized response mean) for these groups was −0.0198 (0.21), 0.0041 (0.05), and 0.0175 (0.21) showing small change and small responsiveness. Conclusions: Proxy CHU9D in 2- to 5-year-old children shows potential but further research is needed.
CHU9D, pediatric, proxy, psychometric properties
Sach, Tracey H.
5c09256f-ebed-4d14-853a-181f6c92d6f2
Williams, Hywel C.
805c7100-2f6e-410c-9418-ed0cad29bac7
10 October 2024
Sach, Tracey H.
5c09256f-ebed-4d14-853a-181f6c92d6f2
Williams, Hywel C.
805c7100-2f6e-410c-9418-ed0cad29bac7
Sach, Tracey H. and Williams, Hywel C.
,
the BEEP study team and et al.
(2024)
Practicality, validity and responsiveness of using the proxy version of the CHU-9D with children aged 2 to 5 years: use of the proxy CHU-9D for children aged 2 to 5.
Value in Health.
(doi:10.1016/j.jval.2024.08.010).
Abstract
Objectives: This study aimed to assess the practicality, validity, and responsiveness of the proxy Child Health Utility–9 Dimensions (CHU9D) in children aged 2 to 5 years. Methods: We used data from the Barrier Enhancement for Eczema Prevention trial, a UK randomized controlled trial testing whether daily emollients in infancy could prevent eczema in high-risk infants. The main parent/carer completed the proxy CHU9D using developers’ additional guidance for completion in those younger than 5 years and the Patient-Oriented Eczema Measure (POEM) at ages 2, 3, 4, and 5 years. Practicality was assessed by completion rates. Construct validity assessed whether CHU9D could discriminate between those with/without eczema and between eczema severity levels on POEM. Responsiveness was determined by ability to discriminate between 3 groups: (1) those whose POEM score deteriorated ≥3 points, (2) those whose change was not clinically important (−2.9 to 2.9 points), and (3) those whose POEM score improved ≥3 points. Analysis was conducted in Stata 17. Results: Of 1394 children participating in the Barrier Enhancement for Eczema Prevention trial, study questionnaires were completed by 1212 (87%), 981 (70%), 990 (71%), and 976 (70%) at 2, 3, 4, and 5 years. Of these the CHU9D was completed by 1066 (88.0%), 685 (69.8%), 925 (93.4%), and 923 (94.6%), respectively. Mean utility at all time points was approximately 0.934 (range 0.443-1). For construct validity, very small differences in the CHU9D between known groups were observed (P < .01). A total of 801 participants had responsiveness data: 13% deteriorated, 72% had nonclinically important change, and 15% improved. Mean utility change (standardized response mean) for these groups was −0.0198 (0.21), 0.0041 (0.05), and 0.0175 (0.21) showing small change and small responsiveness. Conclusions: Proxy CHU9D in 2- to 5-year-old children shows potential but further research is needed.
Text
Accepted version
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
1-s2.0-S1098301524028614-main
- Proof
More information
Accepted/In Press date: 19 August 2024
e-pub ahead of print date: 10 October 2024
Published date: 10 October 2024
Additional Information:
Publisher Copyright:
© 2024
Keywords:
CHU9D, pediatric, proxy, psychometric properties
Identifiers
Local EPrints ID: 495187
URI: http://eprints.soton.ac.uk/id/eprint/495187
ISSN: 1098-3015
PURE UUID: f6553789-e7d3-4f0b-9773-e854ae2de998
Catalogue record
Date deposited: 31 Oct 2024 17:36
Last modified: 21 Nov 2024 03:06
Export record
Altmetrics
Contributors
Author:
Tracey H. Sach
Author:
Hywel C. Williams
Corporate Author: the BEEP study team
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics